Breast Biopsy Market By Product (Vacuum Assisted Biopsy, Core Needle Biopsy, Fine Needle Aspiration Biopsy), By Image Guided Technology (Mri Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, Ct Guided Biopsy, Other Image Guided Breast Biopsy), By End User (Hospitals And Clinics, Diagnostic Centers): Global Opportunity Analysis and Industry Forecast, 2020-2030

Breast Biopsy Market

The Breast Biopsy market may be segmented using a variety of approaches.Breast biopsies are commonly done with Fine Needle Aspiration Biopsy, which is one of the least invasive procedures available and leaves no scarring. A needle is introduced through the dermal tissue of the breast to remove tissue. The other method involves using ultrasound radiation to guide the biopsy, which is also known as stereotactic needle biopsy in conjunction with a mammogram. During this treatment, the ultrasound monitor guides the needle to the target spot in the breast. Stereotactic mammography uses images acquired from various angles to pinpoint the site of the breast tumor, as well as where the needle will be put to get a breast biopsy sample.

Breast biopsy is a diagnostic process used to see if a small sample of breast tissue removed is malignant or not. A breast biopsy helps in locating the diseased tissue in breast and helps in further diagnosis. Factors that contribute to the rise in breast biopsy market are surge in consumption of alcoholic drinks, lack of exercise, and improper dietary habits. With surge in hormonal imbalance as a result of unhealthy lifestyle is also considered as a prominent factor that contributes in the rise of the market. However, limited awareness among female population and substandard healthcare facilities are factors that restrain the growth of breast biopsy market.

The pandemic of COVID-19 is predicted to have a detrimental impact on breast biopsy market growth. The pandemic had a number of negative consequences for breast biopsy market growth due to shutdown in services related to cancer screening. Owing to lockdowns in several nations to prevent the spread of COVID-19, hospitals, clinics, and diagnostic facilities were unable to deliver biopsy services. The surgeries got delayed due to risk of infections and use of protective equipment and hospital resources was limited to the COVID patients, thus creating a negative impact on breast biopsy market.

The breast biopsy market is segmented on the basis of product, image guided technology, end user, and region. On the basis of product, it is categorized into vacuum-assisted biopsy (VAB), core needle biopsy (CNB), and fine needle aspiration biopsy (FNAB). By image guided technology, it is classified into MRI-guided biopsy, ultrasound guided biopsy, mammography guided stereotactic biopsy, CT-guided biopsy, and others. On the basis of end user, it is bifurcated into clinics diagnostic centers and hospitals. By region, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Germany, Russia, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, Singapore, Philippines, and rest of Asia-Pacific), and LAMEA (Brazil, Turkey, Israel, Saudi Arabia, South Africa, and rest of LAMEA).

The list of key players included in the report include Becton, Dickinson & company, Hologic, Inc., Cell-Signalling Technology, Danaher, QIAGEN, Illumina, Fujifilm, Medtronic, Bio-rad and Thermo Fisher Scientific Corp.

The other players in the value chain include Zenalux Biomedical, Inc., F. Hoffmann-La Roche Ltd., OncoCyte Corporation, Laboratory Corporation of America Holdings (Labcorp), Scion Medical Technologies, Planmed Oy, Aurora Imaging Technology Inc., Carestream Health, Cardinal Health, and PerkinElmer.

KEY BENEFITS FOR STAKEHOLDERS

The study gives a top to bottom investigation of the breast biopsy market, with most recent things and future appraisals to explain the imminent investment pockets.

It gives a quantitative investigation from 2020 to 2030 to engage the accomplices to gain by prevailing market opportunities.

Wide investigation by product type and end user determines the various trends and prevailing opportunities in the different market.

Complete examination of all land regions is given, which assist with determining the main opportunities.

Key market players are profiled and their strategies are investigated totally to expect the relentless standpoint of the market.

Scope of Breast Biopsy Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Vacuum Assisted Biopsy

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.3 Core Needle Biopsy

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

4.4 Fine Needle Aspiration Biopsy

4.4.1 Key market trends, growth factors and opportunities

4.4.2 Market size and forecast, by region

4.4.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 Mri Guided Breast Biopsy

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market analysis by country

5.3 Ultrasound Guided Breast Biopsy

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market analysis by country

5.4 Mammography Guided Stereotactic Biopsy

5.4.1 Key market trends, growth factors and opportunities

5.4.2 Market size and forecast, by region

5.4.3 Market analysis by country

5.5 Ct Guided Biopsy

5.5.1 Key market trends, growth factors and opportunities

5.5.2 Market size and forecast, by region

5.5.3 Market analysis by country

5.6 Other Image Guided Breast Biopsy

5.6.1 Key market trends, growth factors and opportunities

5.6.2 Market size and forecast, by region

5.6.3 Market analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 Hospitals And Clinics

6.2.1 Key market trends, growth factors and opportunities

6.2.2 Market size and forecast, by region

6.2.3 Market analysis by country

6.3 Diagnostic Centers

6.3.1 Key market trends, growth factors and opportunities

6.3.2 Market size and forecast, by region

6.3.3 Market analysis by country

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key trends and opportunities

7.2.2 North America Market size and forecast, by Product

7.2.3 North America Market size and forecast, by Image Guided Technology

7.2.4 North America Market size and forecast, by End User

7.2.5 North America Market size and forecast, by country

7.2.5.1 U.S.

7.2.5.1.1 Market size and forecast, by Product

7.2.5.1.2 Market size and forecast, by Image Guided Technology

7.2.5.1.3 Market size and forecast, by End User

7.2.5.2 Canada

7.2.5.2.1 Market size and forecast, by Product

7.2.5.2.2 Market size and forecast, by Image Guided Technology

7.2.5.2.3 Market size and forecast, by End User

7.2.5.3 Mexico

7.2.5.3.1 Market size and forecast, by Product

7.2.5.3.2 Market size and forecast, by Image Guided Technology

7.2.5.3.3 Market size and forecast, by End User

7.3 Europe

7.3.1 Key trends and opportunities

7.3.2 Europe Market size and forecast, by Product

7.3.3 Europe Market size and forecast, by Image Guided Technology

7.3.4 Europe Market size and forecast, by End User

7.3.5 Europe Market size and forecast, by country

7.3.5.1 France

7.3.5.1.1 Market size and forecast, by Product

7.3.5.1.2 Market size and forecast, by Image Guided Technology

7.3.5.1.3 Market size and forecast, by End User

7.3.5.2 Germany

7.3.5.2.1 Market size and forecast, by Product

7.3.5.2.2 Market size and forecast, by Image Guided Technology

7.3.5.2.3 Market size and forecast, by End User

7.3.5.3 U.K.

7.3.5.3.1 Market size and forecast, by Product

7.3.5.3.2 Market size and forecast, by Image Guided Technology

7.3.5.3.3 Market size and forecast, by End User

7.3.5.4 Italy

7.3.5.4.1 Market size and forecast, by Product

7.3.5.4.2 Market size and forecast, by Image Guided Technology

7.3.5.4.3 Market size and forecast, by End User

7.3.5.5 Spain

7.3.5.5.1 Market size and forecast, by Product

7.3.5.5.2 Market size and forecast, by Image Guided Technology

7.3.5.5.3 Market size and forecast, by End User

7.3.5.6 Rest of Europe

7.3.5.6.1 Market size and forecast, by Product

7.3.5.6.2 Market size and forecast, by Image Guided Technology

7.3.5.6.3 Market size and forecast, by End User

7.4 Asia-Pacific

7.4.1 Key trends and opportunities

7.4.2 Asia-Pacific Market size and forecast, by Product

7.4.3 Asia-Pacific Market size and forecast, by Image Guided Technology

7.4.4 Asia-Pacific Market size and forecast, by End User

7.4.5 Asia-Pacific Market size and forecast, by country

7.4.5.1 Japan

7.4.5.1.1 Market size and forecast, by Product

7.4.5.1.2 Market size and forecast, by Image Guided Technology

7.4.5.1.3 Market size and forecast, by End User

7.4.5.2 China

7.4.5.2.1 Market size and forecast, by Product

7.4.5.2.2 Market size and forecast, by Image Guided Technology

7.4.5.2.3 Market size and forecast, by End User

7.4.5.3 Australia

7.4.5.3.1 Market size and forecast, by Product

7.4.5.3.2 Market size and forecast, by Image Guided Technology

7.4.5.3.3 Market size and forecast, by End User

7.4.5.4 India

7.4.5.4.1 Market size and forecast, by Product

7.4.5.4.2 Market size and forecast, by Image Guided Technology

7.4.5.4.3 Market size and forecast, by End User

7.4.5.5 South Korea

7.4.5.5.1 Market size and forecast, by Product

7.4.5.5.2 Market size and forecast, by Image Guided Technology

7.4.5.5.3 Market size and forecast, by End User

7.4.5.6 Rest of Asia-Pacific

7.4.5.6.1 Market size and forecast, by Product

7.4.5.6.2 Market size and forecast, by Image Guided Technology

7.4.5.6.3 Market size and forecast, by End User

7.5 LAMEA

7.5.1 Key trends and opportunities

7.5.2 LAMEA Market size and forecast, by Product

7.5.3 LAMEA Market size and forecast, by Image Guided Technology

7.5.4 LAMEA Market size and forecast, by End User

7.5.5 LAMEA Market size and forecast, by country

7.5.5.1 Brazil

7.5.5.1.1 Market size and forecast, by Product

7.5.5.1.2 Market size and forecast, by Image Guided Technology

7.5.5.1.3 Market size and forecast, by End User

7.5.5.2 Saudi Arabia

7.5.5.2.1 Market size and forecast, by Product

7.5.5.2.2 Market size and forecast, by Image Guided Technology

7.5.5.2.3 Market size and forecast, by End User

7.5.5.3 South Africa

7.5.5.3.1 Market size and forecast, by Product

7.5.5.3.2 Market size and forecast, by Image Guided Technology

7.5.5.3.3 Market size and forecast, by End User

7.5.5.4 Rest of LAMEA

7.5.5.4.1 Market size and forecast, by Product

7.5.5.4.2 Market size and forecast, by Image Guided Technology

7.5.5.4.3 Market size and forecast, by End User

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Key developments

9.1 Ethicon Endo Surgery

9.1.1 Company overview

9.1.2 Company snapshot

9.1.3 Operating business segments

9.1.4 Product portfolio

9.1.5 Business performance

9.1.6 Key strategic moves and developments

9.2 Intact Medical Corporation

9.2.1 Company overview

9.2.2 Company snapshot

9.2.3 Operating business segments

9.2.4 Product portfolio

9.2.5 Business performance

9.2.6 Key strategic moves and developments

9.3 Galini SRL

9.3.1 Company overview

9.3.2 Company snapshot

9.3.3 Operating business segments

9.3.4 Product portfolio

9.3.5 Business performance

9.3.6 Key strategic moves and developments

9.4 Hologic Inc.

9.4.1 Company overview

9.4.2 Company snapshot

9.4.3 Operating business segments

9.4.4 Product portfolio

9.4.5 Business performance

9.4.6 Key strategic moves and developments

9.5 Leica Biosystems Nussloch GmbH

9.5.1 Company overview

9.5.2 Company snapshot

9.5.3 Operating business segments

9.5.4 Product portfolio

9.5.5 Business performance

9.5.6 Key strategic moves and developments

9.6 C. R. Bard, Inc.

9.6.1 Company overview

9.6.2 Company snapshot

9.6.3 Operating business segments

9.6.4 Product portfolio

9.6.5 Business performance

9.6.6 Key strategic moves and developments

9.7 Becton and Dickinson Company

9.7.1 Company overview

9.7.2 Company snapshot

9.7.3 Operating business segments

9.7.4 Product portfolio

9.7.5 Business performance

9.7.6 Key strategic moves and developments

9.8 Argon Medical Devices

9.8.1 Company overview

9.8.2 Company snapshot

9.8.3 Operating business segments

9.8.4 Product portfolio

9.8.5 Business performance

9.8.6 Key strategic moves and developments

9.9 Cook Medical Incorporated

9.9.1 Company overview

9.9.2 Company snapshot

9.9.3 Operating business segments

9.9.4 Product portfolio

9.9.5 Business performance

9.9.6 Key strategic moves and developments

9.10 Encapsule medical Devices LLC.

9.10.1 Company overview

9.10.2 Company snapshot

9.10.3 Operating business segments

9.10.4 Product portfolio

9.10.5 Business performance

9.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 2. BREAST BIOPSY MARKET REVENUE, FOR VACUUM ASSISTED BIOPSY, BY REGION , 2020-2030,($MILLION)

TABLE 3. BREAST BIOPSY MARKET FOR VACUUM ASSISTED BIOPSY BY COUNTRY, 2020-2030,($MILLION)

TABLE 4. BREAST BIOPSY MARKET REVENUE, FOR CORE NEEDLE BIOPSY, BY REGION , 2020-2030,($MILLION)

TABLE 5. BREAST BIOPSY MARKET FOR CORE NEEDLE BIOPSY BY COUNTRY, 2020-2030,($MILLION)

TABLE 6. BREAST BIOPSY MARKET REVENUE, FOR FINE NEEDLE ASPIRATION BIOPSY, BY REGION , 2020-2030,($MILLION)

TABLE 7. BREAST BIOPSY MARKET FOR FINE NEEDLE ASPIRATION BIOPSY BY COUNTRY, 2020-2030,($MILLION)

TABLE 8. GLOBAL BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 9. BREAST BIOPSY MARKET REVENUE, FOR MRI GUIDED BREAST BIOPSY, BY REGION , 2020-2030,($MILLION)

TABLE 10. BREAST BIOPSY MARKET FOR MRI GUIDED BREAST BIOPSY BY COUNTRY, 2020-2030,($MILLION)

TABLE 11. BREAST BIOPSY MARKET REVENUE, FOR ULTRASOUND GUIDED BREAST BIOPSY, BY REGION , 2020-2030,($MILLION)

TABLE 12. BREAST BIOPSY MARKET FOR ULTRASOUND GUIDED BREAST BIOPSY BY COUNTRY, 2020-2030,($MILLION)

TABLE 13. BREAST BIOPSY MARKET REVENUE, FOR MAMMOGRAPHY GUIDED STEREOTACTIC BIOPSY, BY REGION , 2020-2030,($MILLION)

TABLE 14. BREAST BIOPSY MARKET FOR MAMMOGRAPHY GUIDED STEREOTACTIC BIOPSY BY COUNTRY, 2020-2030,($MILLION)

TABLE 15. BREAST BIOPSY MARKET REVENUE, FOR CT GUIDED BIOPSY, BY REGION , 2020-2030,($MILLION)

TABLE 16. BREAST BIOPSY MARKET FOR CT GUIDED BIOPSY BY COUNTRY, 2020-2030,($MILLION)

TABLE 17. BREAST BIOPSY MARKET REVENUE, FOR OTHER IMAGE GUIDED BREAST BIOPSY, BY REGION , 2020-2030,($MILLION)

TABLE 18. BREAST BIOPSY MARKET FOR OTHER IMAGE GUIDED BREAST BIOPSY BY COUNTRY, 2020-2030,($MILLION)

TABLE 19. GLOBAL BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 20. BREAST BIOPSY MARKET REVENUE, FOR HOSPITALS AND CLINICS, BY REGION , 2020-2030,($MILLION)

TABLE 21. BREAST BIOPSY MARKET FOR HOSPITALS AND CLINICS BY COUNTRY, 2020-2030,($MILLION)

TABLE 22. BREAST BIOPSY MARKET REVENUE, FOR DIAGNOSTIC CENTERS, BY REGION , 2020-2030,($MILLION)

TABLE 23. BREAST BIOPSY MARKET FOR DIAGNOSTIC CENTERS BY COUNTRY, 2020-2030,($MILLION)

TABLE 24. BREAST BIOPSY MARKET, BY REGION, 2020-2030,($MILLION)

TABLE 25. NORTH AMERICA BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 26. NORTH AMERICA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 27. NORTH AMERICA BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 28. NORTH AMERICA BREAST BIOPSY MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 29. U.S. BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 30. U.S. BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 31. U.S. BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 32. CANADA BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 33. CANADA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 34. CANADA BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 35. MEXICO BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 36. MEXICO BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 37. MEXICO BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 38. EUROPE BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 39. EUROPE BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 40. EUROPE BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 41. EUROPE BREAST BIOPSY MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 42. FRANCE BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 43. FRANCE BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 44. FRANCE BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 45. GERMANY BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 46. GERMANY BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 47. GERMANY BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 48. U.K. BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 49. U.K. BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 50. U.K. BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 51. ITALY BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 52. ITALY BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 53. ITALY BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 54. SPAIN BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 55. SPAIN BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 56. SPAIN BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 57. REST OF EUROPE BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 58. REST OF EUROPE BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 59. REST OF EUROPE BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 60. ASIA-PACIFIC BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 61. ASIA-PACIFIC BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 62. ASIA-PACIFIC BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 63. ASIA-PACIFIC BREAST BIOPSY MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 64. JAPAN BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 65. JAPAN BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 66. JAPAN BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 67. CHINA BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 68. CHINA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 69. CHINA BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 70. AUSTRALIA BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 71. AUSTRALIA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 72. AUSTRALIA BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 73. INDIA BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 74. INDIA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 75. INDIA BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 76. SOUTH KOREA BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 77. SOUTH KOREA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 78. SOUTH KOREA BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 79. REST OF ASIA-PACIFIC BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 80. REST OF ASIA-PACIFIC BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 81. REST OF ASIA-PACIFIC BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 82. LAMEA BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 83. LAMEA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 84. LAMEA BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 85. LAMEA BREAST BIOPSY MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 86. BRAZIL BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 87. BRAZIL BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 88. BRAZIL BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 89. SAUDI ARABIA BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 90. SAUDI ARABIA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 91. SAUDI ARABIA BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 92. SOUTH AFRICA BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 93. SOUTH AFRICA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 94. SOUTH AFRICA BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 95. REST OF LAMEA BREAST BIOPSY MARKET, BY PRODUCT, 2020-2030,($MILLION)

TABLE 96. REST OF LAMEA BREAST BIOPSY MARKET, BY IMAGE GUIDED TECHNOLOGY, 2020-2030,($MILLION)

TABLE 97. REST OF LAMEA BREAST BIOPSY MARKET, BY END USER, 2020-2030,($MILLION)

TABLE 98.ETHICON ENDO SURGERY: COMPANY SNAPSHOT

TABLE 99.ETHICON ENDO SURGERY: OPERATING SEGMENTS

TABLE 100.ETHICON ENDO SURGERY: PRODUCT PORTFOLIO

TABLE 101.ETHICON ENDO SURGERY: NET SALES,

TABLE 102.ETHICON ENDO SURGERY: KEY STRATERGIES

TABLE 103.INTACT MEDICAL CORPORATION: COMPANY SNAPSHOT

TABLE 104.INTACT MEDICAL CORPORATION: OPERATING SEGMENTS

TABLE 105.INTACT MEDICAL CORPORATION: PRODUCT PORTFOLIO

TABLE 106.INTACT MEDICAL CORPORATION: NET SALES,

TABLE 107.INTACT MEDICAL CORPORATION: KEY STRATERGIES

TABLE 108.GALINI SRL: COMPANY SNAPSHOT

TABLE 109.GALINI SRL: OPERATING SEGMENTS

TABLE 110.GALINI SRL: PRODUCT PORTFOLIO

TABLE 111.GALINI SRL: NET SALES,

TABLE 112.GALINI SRL: KEY STRATERGIES

TABLE 113.HOLOGIC INC.: COMPANY SNAPSHOT

TABLE 114.HOLOGIC INC.: OPERATING SEGMENTS

TABLE 115.HOLOGIC INC.: PRODUCT PORTFOLIO

TABLE 116.HOLOGIC INC.: NET SALES,

TABLE 117.HOLOGIC INC.: KEY STRATERGIES

TABLE 118.LEICA BIOSYSTEMS NUSSLOCH GMBH: COMPANY SNAPSHOT

TABLE 119.LEICA BIOSYSTEMS NUSSLOCH GMBH: OPERATING SEGMENTS

TABLE 120.LEICA BIOSYSTEMS NUSSLOCH GMBH: PRODUCT PORTFOLIO

TABLE 121.LEICA BIOSYSTEMS NUSSLOCH GMBH: NET SALES,

TABLE 122.LEICA BIOSYSTEMS NUSSLOCH GMBH: KEY STRATERGIES

TABLE 123.C. R. BARD, INC.: COMPANY SNAPSHOT

TABLE 124.C. R. BARD, INC.: OPERATING SEGMENTS

TABLE 125.C. R. BARD, INC.: PRODUCT PORTFOLIO

TABLE 126.C. R. BARD, INC.: NET SALES,

TABLE 127.C. R. BARD, INC.: KEY STRATERGIES

TABLE 128.BECTON AND DICKINSON COMPANY: COMPANY SNAPSHOT

TABLE 129.BECTON AND DICKINSON COMPANY: OPERATING SEGMENTS

TABLE 130.BECTON AND DICKINSON COMPANY: PRODUCT PORTFOLIO

TABLE 131.BECTON AND DICKINSON COMPANY: NET SALES,

TABLE 132.BECTON AND DICKINSON COMPANY: KEY STRATERGIES

TABLE 133.ARGON MEDICAL DEVICES: COMPANY SNAPSHOT

TABLE 134.ARGON MEDICAL DEVICES: OPERATING SEGMENTS

TABLE 135.ARGON MEDICAL DEVICES: PRODUCT PORTFOLIO

TABLE 136.ARGON MEDICAL DEVICES: NET SALES,

TABLE 137.ARGON MEDICAL DEVICES: KEY STRATERGIES

TABLE 138.COOK MEDICAL INCORPORATED: COMPANY SNAPSHOT

TABLE 139.COOK MEDICAL INCORPORATED: OPERATING SEGMENTS

TABLE 140.COOK MEDICAL INCORPORATED: PRODUCT PORTFOLIO

TABLE 141.COOK MEDICAL INCORPORATED: NET SALES,

TABLE 142.COOK MEDICAL INCORPORATED: KEY STRATERGIES

TABLE 143.ENCAPSULE MEDICAL DEVICES LLC.: COMPANY SNAPSHOT

TABLE 144.ENCAPSULE MEDICAL DEVICES LLC.: OPERATING SEGMENTS

TABLE 145.ENCAPSULE MEDICAL DEVICES LLC.: PRODUCT PORTFOLIO

TABLE 146.ENCAPSULE MEDICAL DEVICES LLC.: NET SALES,

TABLE 147.ENCAPSULE MEDICAL DEVICES LLC.: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.BREAST BIOPSY MARKET SEGMENTATION

FIGURE 2.BREAST BIOPSY MARKET,2020-2030

FIGURE 3.BREAST BIOPSY MARKET,2020-2030

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.BREAST BIOPSY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 12.BREAST BIOPSY MARKET,BY PRODUCT,2020(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF VACUUM ASSISTED BIOPSY BREAST BIOPSY MARKET,2020-2030(%)

FIGURE 14.COMPARATIVE SHARE ANALYSIS OF CORE NEEDLE BIOPSY BREAST BIOPSY MARKET,2020-2030(%)

FIGURE 15.COMPARATIVE SHARE ANALYSIS OF FINE NEEDLE ASPIRATION BIOPSY BREAST BIOPSY MARKET,2020-2030(%)

FIGURE 16.BREAST BIOPSY MARKET,BY IMAGE GUIDED TECHNOLOGY,2020(%)

FIGURE 17.COMPARATIVE SHARE ANALYSIS OF MRI GUIDED BREAST BIOPSY BREAST BIOPSY MARKET,2020-2030(%)

FIGURE 18.COMPARATIVE SHARE ANALYSIS OF ULTRASOUND GUIDED BREAST BIOPSY BREAST BIOPSY MARKET,2020-2030(%)

FIGURE 19.COMPARATIVE SHARE ANALYSIS OF MAMMOGRAPHY GUIDED STEREOTACTIC BIOPSY BREAST BIOPSY MARKET,2020-2030(%)

FIGURE 20.COMPARATIVE SHARE ANALYSIS OF CT GUIDED BIOPSY BREAST BIOPSY MARKET,2020-2030(%)

FIGURE 21.COMPARATIVE SHARE ANALYSIS OF OTHER IMAGE GUIDED BREAST BIOPSY BREAST BIOPSY MARKET,2020-2030(%)

FIGURE 22.BREAST BIOPSY MARKET,BY END USER,2020(%)

FIGURE 23.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS BREAST BIOPSY MARKET,2020-2030(%)

FIGURE 24.COMPARATIVE SHARE ANALYSIS OF DIAGNOSTIC CENTERS BREAST BIOPSY MARKET,2020-2030(%)

FIGURE 25.BREAST BIOPSY MARKET BY REGION,2020

FIGURE 26.U.S. BREAST BIOPSY MARKET,2020-2030($MILLION)

FIGURE 27.CANADA BREAST BIOPSY MARKET,2020-2030($MILLION)

FIGURE 28.MEXICO BREAST BIOPSY MARKET,2020-2030($MILLION)

FIGURE 29.FRANCE BREAST BIOPSY MARKET,2020-2030($MILLION)

FIGURE 30.GERMANY BREAST BIOPSY MARKET,2020-2030($MILLION)

FIGURE 31.U.K. BREAST BIOPSY MARKET,2020-2030($MILLION)

FIGURE 32.ITALY BREAST BIOPSY MARKET,2020-2030($MILLION)

FIGURE 33.SPAIN BREAST BIOPSY MARKET,2020-2030($MILLION)

FIGURE 34.REST OF EUROPE BREAST BIOPSY MARKET,2020-2030($MILLION)

FIGURE 35.JAPAN BREAST BIOPSY MARKET,2020-2030($MILLION)

FIGURE 36.CHINA BREAST BIOPSY MARKET,2020-2030($MILLION)

FIGURE 37.AUSTRALIA BREAST BIOPSY MARKET,2020-2030($MILLION)

FIGURE 38.INDIA BREAST BIOPSY MARKET,2020-2030($MILLION)

FIGURE 39.SOUTH KOREA BREAST BIOPSY MARKET,2020-2030($MILLION)

FIGURE 40.REST OF ASIA-PACIFIC BREAST BIOPSY MARKET,2020-2030($MILLION)

FIGURE 41.BRAZIL BREAST BIOPSY MARKET,2020-2030($MILLION)

FIGURE 42.SAUDI ARABIA BREAST BIOPSY MARKET,2020-2030($MILLION)

FIGURE 43.SOUTH AFRICA BREAST BIOPSY MARKET,2020-2030($MILLION)

FIGURE 44.REST OF LAMEA BREAST BIOPSY MARKET,2020-2030($MILLION)

FIGURE 45. TOP WINNING STRATEGIES, BY YEAR

FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 49.COMPETITIVE DASHBOARD

FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 51.ETHICON ENDO SURGERY.: NET SALES ,($MILLION)

FIGURE 52.INTACT MEDICAL CORPORATION.: NET SALES ,($MILLION)

FIGURE 53.GALINI SRL.: NET SALES ,($MILLION)

FIGURE 54.HOLOGIC INC..: NET SALES ,($MILLION)

FIGURE 55.LEICA BIOSYSTEMS NUSSLOCH GMBH.: NET SALES ,($MILLION)

FIGURE 56.C. R. BARD, INC..: NET SALES ,($MILLION)

FIGURE 57.BECTON AND DICKINSON COMPANY.: NET SALES ,($MILLION)

FIGURE 58.ARGON MEDICAL DEVICES.: NET SALES ,($MILLION)

FIGURE 59.COOK MEDICAL INCORPORATED.: NET SALES ,($MILLION)

FIGURE 60.ENCAPSULE MEDICAL DEVICES LLC..: NET SALES ,($MILLION